Usana Health Sciences Inc.’s stock USNA, +1.59% fell 2% before turning flat in after-hours trade Tuesday, after the maker of nutritional supplements missed earnings estimates for the third quarter. Salt Lake City, Utah-based Usana posted net income of $11.3 million, or 59 cents a share, for the quarter, down from $14.9 million, or 78 cents a share, in the year-earlier period. Sales fell to $213.4 million from $233.3 million. The FactSet consensus was for EPS of 64 cents and revenue of $220.
“Operating results for the third quarter did not meet our expectations, largely because of challenging economic conditions across many of our regions and a lower cadence of promotional activity during the quarter,” CEO John Brown said in a statement. “These factors made it difficult to generate both Active Customer growth and top line momentum in our business.” The company lowered its full-year guidance and now expects EPS to range from $2.80 to $3.05, compared with prior guidance of $2.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Teladoc’s stock tumbles after-hours after company misses sales estimates and offers soft guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Weiterlesen »
GE stock climbs premarket after posting better-than-expected Q3 earnings and raising guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Weiterlesen »
Water treatment company Shimmick to offer 4.55 million shares in IPO priced at $10 to $12 eachCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Weiterlesen »
General Motors rises premarket after earnings blow past estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Weiterlesen »